HOME >> MEDICINE >> NEWS
National Jewish Pediatric Asthma Specialist Urges Monitoring Growth When Using Nebulized Glucocorticoids As An Asthma Treatment In Children

DENVER-Using a nebulizer as a delivery system for glucocorticoid medication is effective in treating asthma in children, but a National Jewish Medical and Research Center physician recommends continued caution in using the medication because of the drug's possible impact on a child's growth.

For the past 10 years, physicians in the United States have anticipated a Food and Drug Administration-approved glucocorticoid in a nebulized version for children five and younger. (It's been available in Europe for the past several years.) Currently, inhalers are the main way to deliver the medication. Because inhalers are difficult for a child to control, only a very small amount of the drug reaches the lungs. "It's a challenge for children less than three years old," says Stanley J. Szefler, M.D., director of Clinical Pharmacology at National Jewish.

Dr. Szefler's editorial accompanies an article about a new glucocorticoid clinical trial, which appears in the November issue of the Journal of Allergy and Clinical Immunology. The editorial suggests physicians continue to use caution when prescribing a glucocorticoid for a child, especially those under 5 years old, because long-term use, especially with high doses, can suppress growth.

"The movement is to support early diagnosis and intervention of asthma," says Dr. Szefler, who is a member of the Food and Drug Administration Pulmonary-Allergy Drug Advisory Committee. "More information is becoming available for the safe and effective use of inhaled steroids in younger children. In older children and adults, inhaled steroids are recognized as the preferred method for long-term asthma control."

The newly-published study is one of only a few that have probed the safety and effectiveness of using a nebulizer, a device that suspends medication in a mist that is breathed through a mask, for the delivery of glucocorticoids in children. Glucoc
'"/>

Contact: Jordan Gruener
gruenerj@njc.org
303-398-1002
National Jewish Medical and Research Center
12-Nov-1998


Page: 1 2

Related medicine news :

1. National Academies advisory: May 2 Symposium on International Science Policy
2. National Academies News: William H. Foege to receive Public Welfare Medal, Academys highest honor
3. National Academies news: Academy honors 17 for major contributions to science
4. National Academies advisory: Report assesses health implications of perchlorate exposure
5. National Academies Advisory: Jan. 11 public briefing on perchlorate in drinking water
6. National Academies news: Gulf War and Health
7. National survey shows few physicians elected to Congress
8. Six new Roybal Centers for Applied Gerontology established by National Institute on Aging
9. UGA professor receives $3 million grant from National Cancer Institute for breast cancer research
10. National Academies advisory: Nov. 4-6 Frontiers of Science meeting in Irvine, Calif.
11. National Chemistry Week celebrates health and wellness in Washington, D.C., area

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:7/31/2020)... , ... July 31, 2020 , ... ... health plans, is announcing an expansion of clinical & technical capabilities to cover ... the most complete back and joint health solution. , Currently, employers interested ...
(Date:7/22/2020)... ... July 22, 2020 , ... With Covid-19 and the ... world has changed, and there’s no going back. In confronting our discomfort during ... us temporarily manage emotional struggles, healing is the approach we should strive for. ...
(Date:7/18/2020)... ... , ... A June 2 article on Daily Mail reported on a fitness model ... augmentations. The article says that her first procedure, unbeknownst to her, was performed by a ... surgeon to revise her procedure, only to find out the doctor did not have the ...
(Date:7/18/2020)... ... , ... Nader Sanai, M.D., director of the Ivy Brain Tumor Center at ... Glioblastoma Awareness Day (#GBMDay) on July 22, 2020 to raise national consciousness. , ... , the most common and aggressive form of brain cancer. It also honors those ...
(Date:7/10/2020)... ... July 10, 2020 , ... ... 2020 that, in line with Circularity Healthcare’s mission to provide real and affordable ... nature and to help prevent future pandemics by ending the commercial trade in ...
Breaking Medicine News(10 mins):
(Date:7/31/2020)... ... ... Member Care Solutions announced a deal with American Family Care (AFC) that ... their cloud based membership management software platform. , “We are very pleased and excited ... perfect match for many reasons, but AFC’s need to quickly set up, market, track ...
(Date:7/22/2020)... ... 22, 2020 , ... TrialScope, the global leader in clinical ... Moderna to its growing customer roster. , TrialScope customers include 16 of the ... patient engagement and study recruitment. Collectively, TrialScope customers are responsible for more than ...
(Date:7/18/2020)... , ... July 17, 2020 , ... ... COVID-19,” an extensive awareness campaign to let those who are experiencing abuse know ... seek the services they need through the Miami-Dade County’s Coordinated Victim’s Assistance Center ...
Breaking Medicine Technology:
Cached News: